Journal of Cancer Research and Therapeutics Close
 

Figure 1: Expression of CD5 and CD19 markers in B-cells of patients with chronic lymphocytic leukemia. Cut-off point 20%, after subtracting the background color using the same isotype as the negative control conjugated antibody. In this study, B-cells isolated from all 21 chronic lymphocytic leukemia patients were considered positive

Figure 1: Expression of CD5 and CD19 markers in B-cells of patients with chronic lymphocytic leukemia. Cut-off point 20%, after subtracting the background color using the same isotype as the negative control conjugated antibody. In this study, B-cells isolated from all 21 chronic lymphocytic leukemia patients were considered positive